Cargando…

Toward improved models of human cancer

Human cancer is a complex and heterogeneous collection of diseases that kills more than 18 million people every year worldwide. Despite advances in detection, diagnosis, and treatments for cancers, new strategies are needed to combat deadly cancers. Models of human cancer continue to evolve for prec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welm, Bryan E., Vaklavas, Christos, Welm, Alana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AIP Publishing LLC 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785323/ https://www.ncbi.nlm.nih.gov/pubmed/33415312 http://dx.doi.org/10.1063/5.0030534

Ejemplares similares

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003
por: Welm, Alana L
Publicado: (2004)

Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research
por: Stires, Hillary, et al.
Publicado: (2022)

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
por: Faham, Najme, et al.
Publicado: (2018)

Breast cancer PDxO cultures for drug discovery and functional precision oncology
por: Scherer, Sandra D., et al.
Publicado: (2023)

The lingering mysteries of metastatic recurrence in breast cancer
por: Riggio, Alessandra I., et al.
Publicado: (2020)

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

Short-form Ron is a novel determinant of ovarian cancer initiation and progression
por: Moxley, Katherine M., et al.
Publicado: (2016)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Toward improved in vitro models of human cancer
por: Ayuso, Jose M., et al.
Publicado: (2021)

Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression
por: Lai, Shu-Chin Alicia, et al.
Publicado: (2021)

The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress
por: Vaden, Rachel M, et al.
Publicado: (2014)

Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
por: Arnesen, Spencer, et al.
Publicado: (2023)

Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland
por: Welm, Bryan E., et al.
Publicado: (2002)

An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer
por: Scherer, Sandra D., et al.
Publicado: (2021)

Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis
por: Larrieu-Lahargue, Frédéric, et al.
Publicado: (2012)

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
por: Ekiz, Huseyin Atakan, et al.
Publicado: (2018)

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer()
por: Vaklavas, Christos, et al.
Publicado: (2020)

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
por: Palomeras, Sònia, et al.
Publicado: (2019)

A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis
por: Feng, Qiyu, et al.
Publicado: (2017)

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022)

A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer
por: DeVette, Christa I., et al.
Publicado: (2019)

Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphate
por: Wilde, Blake R., et al.
Publicado: (2020)

Toward mapping the human body at a cellular resolution
por: Roy, Ananda L., et al.
Publicado: (2018)

Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential
por: Drobysheva, Daria, et al.
Publicado: (2015)

Towards modelling emergence in plant systems
por: Tomkins, Melissa
Publicado: (2023)

ModelBricks—modules for reproducible modeling improving model annotation and provenance
por: Cowan, Ann E., et al.
Publicado: (2019)

Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells
por: Gligorich, Keith M, et al.
Publicado: (2013)

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion
por: Olson, Michael L., et al.
Publicado: (2022)

It is time to improve the quality of medical information distributed to students across social media
por: Zucker, Benjamin E, et al.
Publicado: (2018)

Plasma exosome microRNAs are indicative of breast cancer
por: Hannafon, Bethany N., et al.
Publicado: (2016)

Using our mini-brains: cerebral organoids as an improved cellular model for human prion disease
por: Groveman, Bradley R., et al.
Publicado: (2019)

Toward Personalized Control of Human Gut Bacterial Communities
por: David, Lawrence A.
Publicado: (2018)

The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
por: Cunha, Stéphanie, et al.
Publicado: (2014)

Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare
por: Feng, Jean, et al.
Publicado: (2022)

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
por: Kinsey, Conan G., et al.
Publicado: (2019)

Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
por: Vaklavas, Christos, et al.
Publicado: (2017)

Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines
por: Kessie, David Komla, et al.
Publicado: (2021)

Modeling the developmental origins of pediatric cancer to improve patient outcomes
por: Amatruda, James F.
Publicado: (2021)

Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration
por: Szepanowski, Fabian, et al.
Publicado: (2016)

Towards a methodology for testing models as hypotheses in the inexact sciences
por: Beven, Keith
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qi0ensej40ehh1nv58i5bb9dl4